Folate intake and the risk of upper gastrointestinal cancers: A systematic review and meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 2, 2014, Pages 250-258

  Tio, Martin ^a   Andrici, Juliana ^a   Cox, Michael R ^a   Eslick, Guy D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Esophageal cancer; Folate; Folic acid; Gastric cancer; Pancreatic cancer

Indexed keywords

FOLIC ACID;

BLOOD LEVEL; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FOLIC ACID DEFICIENCY; FOOD INTAKE; HUMAN; META ANALYSIS; META ANALYSIS (TOPIC); PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; STOMACH CANCER; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL CANCER; UPPER GASTROINTESTINAL TRACT; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; ESOPHAGUS TUMOR; MEDLINE; PANCREAS TUMOR; RISK;

ESOPHAGEAL CANCER; FOLATE; FOLIC ACID; GASTRIC CANCER; PANCREATIC CANCER;

ESOPHAGEAL NEOPLASMS; FOLIC ACID; HUMANS; PANCREATIC NEOPLASMS; PUBMED; RISK;

EID: 84907280487     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12446     Document Type: Review

References (59)

1. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 2011; 34: 101-109.
2. Blount BC, Mack MM, Wehr CM etal. Folate deficiency causes uracil misincorporation into human DNA and chromosomal breakage implications for cancer and neuronal damage. Proc. Natl Acad. Sci. U. S. A. 1997; 94: 3290-3295.
3. Wasson GR, McGlynn AP, McNulty H etal. Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J. Nutr. 2006; 136: 2748-2753.
4. Charles MA, Johnson IT, Belshaw NJ. Supra-physiological folic acid concentrations induce aberrant DNA methylation in normal human cells in vitro. Epigenetics 2012; 7: 689-694.
5. Sanjoaquin MA, Allen N, Couto E etal. Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer 2005; 113: 825-828.
6. Kennedy DA, Stern SJ, Moretti M etal. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011; 35: 2-10.
7. Carroll C, Cooper K, Papaioannou D etal. Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer. Aliment. Pharmacol. Ther. 2010; 31: 708-718.
8. Xiao SD, Meng XJ, Shi Y etal. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. Gut 2002; 50: 61-64.
9. Gonda TA, Kim YI, Salas MC etal. Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology 2012; 142: 824-833.
10. Sun L, Sun YH, Wang B etal. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis. Eur. J. Cancer Prev. 2008; 17: 446-452.
11. Liu YX, Wang B, Wan MH etal. Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac. J. Cancer Prev. 2011; 12: 247-252.
12. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006; 131: 1271-1283.
13. Stroup DF, Berlin JA, Morton SC, Olkin I etal. Metaanalysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Orwin R. A fail safe N for effect size in meta-analysis. J. Educ. Stat. 1983; 8: 157-159.
18. Aune D, Deneo-Pellegrini H, Ronco AL etal. Dietary folate intake and the risk of 11 types of cancer: a case control study in Uruguay. Ann. Oncol. 2011; 22: 444-451.
19. Baghurst PA, McMichael AJ, Slavotinek AH etal. A case-control study of diet and cancer of the pancreas. Am. J. Epidemiol. 1991; 134: 167-179.
20. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 2000; 88: 737-748.
21. Bravi F, Polesel J, Bosetti C etal. Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann. Oncol. 2011; 22: 202-206.
22. Brown LM, Blot WJ, Schuman SH etal. Environmental factors and high risk of esophageal cancer among men in coastal South Carolina. J. Natl Cancer Inst. 1988; 80: 1620-1625.
23. Chen H, Tucker KL, Gaubard BI etal. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr. Cancer 2002; 42: 33-40.
24. Chuang SC, Stolzenberg-Solomon R, Ueland PM etal. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur. J. Cancer 2011; 47: 1808-1816.
25. Eplein M, Shu XO, Xiang YB etal. Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies. Am. J. Epidemiol. 2010; 172: 397-406.
26. Galeone C, Pelucchi C, Levi F etal. Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men. Ann. Oncol. 2006; 17: 521-525.
27. Gao S, Ding LH, Wang JW etal. Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac. J. Cancer Prev. 2013; 14: 299-302.
28. Gong Z, Holly EA, Bracci PM. Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control 2009; 20: 1317-1325.
29. Guo AZ, Cai QC, Chen Y etal. Relationship of folic acid, homocysteine with pancreatic cancer: a case-control study. Acad. J. Sec. Mil. Med. Univ. 2009; 30: 420-423.
30. Harrison LE, Zhang ZF, Karpeh MS etal. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 1997; 80: 1021-1028.
31. Ibiebele TI, Hughes MC, Pandeya N etal. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. J. Nutr. 2011; 141: 274-283.
32. Jessri M, Rashidkhani B, Hajizadeh B etal. Macronutrients, vitamins and minerals intake and risk of esophageal squamous cell carcinoma: a case-control study in Iran. Nutr. J. 2011; 10: 137.
33. Keszei AP, Verhage BA, Heinen MM etal. Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 1785-1791.
34. Kim HJ, Kim MK, Chang WK etal. Effect of nutrient intake and Helicobacter pylori infection on gastric cancer in Korea: a case-control study. Nutr. Cancer 2005; 52: 138-146.
35. Larsson SC, Giovannucci E, Wolk A. Folate intake and stomach cancer incidence in a prospective cohort of Swedish women. Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1409-1412.
36. Larsson SC, Hakansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J. Natl Cancer Inst. 2006; 98: 407-413.
37. La Vecchia C, Ferraroni M, D'avanzo B etal. Selected micronutrient intake and risk of gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1994; 3: 393-398.
38. Lazarevic K, Nagorni A, Bogdanovic D etal. Dietary micronutrients and gastric cancer: hospital based study. Cent. Eur. J. Med. 2011; 6: 783-787.
39. Lissowska J, Gail MH, Pee D etal. Diet and stomach cancer risk in Warsaw, Poland. Nutr. Cancer 2004; 48: 149-159.
40. Lopez-Carrillo L, Lopez-Cervantes M, Ward MH etal. Nutrient intake and gastric cancer in Mexico. Int. J. Cancer 1999; 83: 601-605.
41. Mayne ST, Risch HA, Dubrow R etal. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 1055-1062.
42. Munoz N, Plummer M, Vivas J etal. A case-control study of gastric cancer in Venezuela. Int. J. Cancer 2001; 93: 417-423.
43. Nomura AM, Hankin JH, Kolonel LN etal. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control 2003; 14: 547-558.
44. Oaks BM, Dodd KW, Meinhold CL etal. Folate Intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr. 2012; 91: 449-455.
45. Pelucchi C, Tramacere I, Bertuccio P etal. Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Ann. Oncol. 2009; 20: 160-165.
46. Qin JM, Wang XM, Chen B etal. Study on the ingestion of folate and polymorphism of MTHFR C677T with esophageal cancer in Xinjiang Kazakh. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29: 30-33.
47. Schernhammer E, Wolpin B, Rifai N etal. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007; 67: 5553-5560.
48. Skinner HG, Michaud DS, Giovannucci EL etal. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am. J. Epidemiol. 2004; 160: 248-258.
49. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ etal. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J. Natl Cancer Inst. 1999; 91: 535-541.
50. Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ etal. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am. J. Epidemiol. 2001; 153: 680-687.
51. Tan W, Miao X, Wang L etal. Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis 2005; 26: 1430-1435.
52. Vollset SE, Iglanf J, Jenab M etal. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2416-2424.
53. Yang CX, Matsuo K, Ito H etal. Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis 2005; 26: 1285-1290.
54. Langevin SM, Lin D, Matsuo K etal. Review and pooled analysis on MTHFR C677T polymorphism and esophageal cancer. Toxicol. Lett. 2009; 184: 73-80.
55. Bailey RL, Gahche JJ, Lentino CV etal. Dietary supplement use in the United States, 2003-2006. J. Nutr. 2011; 141: 261-266.
56. Wien TN, Pike E, Wisloff T etal. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open. 2012; 2: e000653.
57. Eslick GD, Lim LL, Byles JE etal. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am. J. Gastroenterol. 1999; 94: 2373-2379.
58. Boccia S, Hung R, Ricciardi G. Meta- and pooled analyses of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am. J. Epidemiol. 2008; 167: 505-516.
59. Bao Y, Michaud DS, Spiegelman D etal. Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies. J. Natl Cancer Inst. 2011; 103: 1840-1850.